Phillips KA - Search Results

1

Availability and funding of clinical genomic sequencing globally.

Phillips KA, Douglas MP, Wordsworth S, Buchanan J, Marshall DA. Phillips KA, et al. BMJ Glob Health. 2021 Feb;6(2):e004415. doi: 10.1136/bmjgh-2020-004415. BMJ Glob Health. 2021. PMID: 33574068 Free PMC article. Review.

2

A review of studies examining stated preferences for cancer screening.

Phillips KA, Van Bebber S, Marshall D, Walsh J, Thabane L. Phillips KA, et al. Prev Chronic Dis. 2006 Jul;3(3):A75. Epub 2006 Jun 15. Prev Chronic Dis. 2006. PMID: 16776876 Free PMC article.

3

Measuring patient preferences for colorectal cancer screening using a choice-format survey.

Marshall DA, Johnson FR, Phillips KA, Marshall JK, Thabane L, Kulin NA. Marshall DA, et al. Among authors: phillips ka. Value Health. 2007 Sep-Oct;10(5):415-30. doi: 10.1111/j.1524-4733.2007.00196.x. Value Health. 2007. PMID: 17888107 Free article.

4

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.

Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO; EGAPP Working Group. Teutsch SM, et al. Genet Med. 2009 Jan;11(1):3-14. doi: 10.1097/GIM.0b013e318184137c. Genet Med. 2009. PMID: 18813139 Free PMC article.

5

How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey.

Marshall DA, Johnson FR, Kulin NA, Ozdemir S, Walsh JM, Marshall JK, Van Bebber S, Phillips KA. Marshall DA, et al. Among authors: phillips ka. Health Econ. 2009 Dec;18(12):1420-39. doi: 10.1002/hec.1437. Health Econ. 2009. PMID: 19191268 Free PMC article.

6

Addressing the challenges of the clinical application of pharmacogenetic testing.

Ikediobi ON, Shin J, Nussbaum RL, Phillips KA; UCSF Center for Translational and Policy Research on Personalized Medicine; Walsh JM, Ladabaum U, Marshall D. Ikediobi ON, et al. Among authors: phillips ka. Clin Pharmacol Ther. 2009 Jul;86(1):28-31. doi: 10.1038/clpt.2009.30. Clin Pharmacol Ther. 2009. PMID: 19536122 Free PMC article. Review.

7

Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients.

Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL. Phillips KA, et al. Cancer. 2009 Nov 15;115(22):5166-74. doi: 10.1002/cncr.24574. Cancer. 2009. PMID: 19753618 Free PMC article.

8

How does cost matter in health-care discrete-choice experiments?

Johnson FR, Mohamed AF, Ozdemir S, Marshall DA, Phillips KA. Johnson FR, et al. Among authors: phillips ka. Health Econ. 2011 Mar;20(3):323-30. doi: 10.1002/hec.1591. Health Econ. 2011. PMID: 20217834 Free PMC article.

9

Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses.

Ferrusi IL, Marshall DA, Kulin NA, Leighl NB, Phillips KA. Ferrusi IL, et al. Among authors: phillips ka. Per Med. 2009 Mar;6(2):193-215. doi: 10.2217/17410541.6.2.193. Per Med. 2009. PMID: 20668661 Free PMC article.

10

Economic evaluation of targeted cancer interventions: critical review and recommendations.

Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Elkin EB, et al. Among authors: phillips ka. Genet Med. 2011 Oct;13(10):853-60. doi: 10.1097/GIM.0b013e31821f3e64. Genet Med. 2011. PMID: 21637102 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

797 results

Search Page